All stories tagged :

People

Waldencast Announces Q2 2025 Results and Provides Q3 2025 Trading Update

admin
People

Burlington Stores, Inc. Announces First Quarter Fiscal Year 2025 Earnings Release...

admin
People

Super League Reports First Quarter 2025 Financial Results

admin
People

The WHOLE Stepfamily Founder to Host Inaugural Butterfly Ball at Panorama...

admin
People

Moana Beauty Spa Announces Advanced LED Facelift Protocol, Attracting International Clients...

admin
People

MuscleMecca Bodybuilding Forums Announces Expanded Advertising Opportunities for Fitness Brands

admin
People

Vietnam Social Commerce Intelligence Report 2025: Market to Grow by 25.4%...

admin
People

Thailand Social Commerce Intelligence Report 2025: Market to Grow by 18.6%...

admin
People

Saudi Arabia Social Commerce Intelligence Report 2025: Market to Grow by...

admin
People

Middle East Social Commerce Market Intelligence Report 2025: Influencer Partners and...

admin
People

Lulutox Detox Tea Reviews (WARNING): Real Consumer Report Exposed!

admin

Featured

Pr Newswire

Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program...

admin
Pr Newswire

Cardiff Oncology to Present at the Piper Sandler 37th Annual Healthcare...

admin
Pr Newswire

Tilray Unveils Good Supply Vapes in Québec Following the Recent Introduction...

admin
Pr Newswire

Fortrea Completes $75.7 Million Senior Notes Tender Offer Utilizing Cash on...

admin
admin

Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program...

NEW HAVEN, Conn., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that multiple abstracts on vepdegestrant (ARV-471) have been accepted for presentation at the upcoming San Antonio Breast...